ArticleInfection & chemotherapy2024

Call for Balancing the Risks and Benefits of Immunotherapeutic Agents for Lymphoma during the COVID-19 Pandemic.

Chan Mi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.